cantab pharmaceuticals biotechnology company signed agreement californias stanford university gives option acquire exclusive rights family patent applications covering inventions stanfords researchers the two also collaborate research autoimmune inflammatory diseases rheumatoid arthritis ulcerative colitis the deal signals cantabs entry autoimmune inflammatory disease areas the work still research stage any product isolated would go years clinical trials reaching market